(Q36828536)

16 August 2017

Population pharmacokinetics of perphenazine in schizophrenia patients from CATIE: impact of race and smoking (English)

1 reference

16 August 2017

1 reference

1 reference

8

Jeffrey Lieberman

1 reference

16 August 2017

Yuyan Jin

1

1 reference

16 August 2017

Bruce G Pollock

2

1 reference

16 August 2017

Kim Coley

3

1 reference

16 August 2017

Del Miller

4

1 reference

16 August 2017

Stephen R Marder

5

1 reference

16 August 2017

Jeff Florian

6

1 reference

16 August 2017

Lon Schneider

7

1 reference

16 August 2017

Margaret Kirshner

9

1 reference

16 August 2017

Robert R Bies

10

1 reference

16 August 2017

language of work or name

1 reference

20 October 2009

1 reference

The Journal of Clinical Pharmacology

16 August 2017

1 reference

16 August 2017

50

1 reference

16 August 2017

1

1 reference

16 August 2017

73-80

1 reference

The effect of reporting methods for dosing times on the estimation of pharmacokinetic parameters of escitalopram

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

The CATIE schizophrenia trial: results, impact, controversy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

Drug interactions with smoking

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

Factors associated with drug adherence and blood pressure control in patients with hypertension

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

Population pharmacokinetics as a method to detect variable risperidone exposure in patients suffering from dementia with behavioral disturbances

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

The role of population pharmacokinetics in drug development in light of the Food and Drug Administration's 'Guidance for Industry: population pharmacokinetics'.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

Prevalence of smoking among psychiatric outpatients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

Clinical pharmacokinetic studies of perphenazine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

Schizophrenia and smoking: an epidemiological survey in a state hospital

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

Sex, race, and smoking impact olanzapine exposure.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

Racial differences in blood pressure control: potential explanatory factors

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

Modifiable barriers to adherence to inhaled steroids among adults with asthma: it's not just black and white

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

The CYP2D6 genotype predicts the oral clearance of the neuroleptic agents perphenazine and zuclopenthixol.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3648660

Differential prescription of maintenance antipsychotics to African American and white patients with new-onset bipolar disorder

5 September 2018

1 reference

12 December 2020

Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia

1 reference

12 December 2020

Quantitative determination of perphenazine and its metabolites in plasma by high-performance liquid chromatography and coulometric detection

1 reference

12 December 2020

Time and theophylline concentration help explain the recovery of peak flow following acute airways obstruction. Population analysis of a randomised concentration controlled trial

1 reference

12 December 2020

Theophylline target concentration in severe airways obstruction - 10 or 20 mg/L? A randomised concentration-controlled trial

1 reference

12 December 2020

Smoking and schizophrenia

1 reference

12 December 2020

Dopamine receptors, neuroleptics, and schizophrenia

1 reference

12 December 2020

Identifiers

DOI

10.1177/0091270009343694

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

19843655

1 reference